Small Cap Wrap - Strix Group, ProPhotonix, Nostra Terra Oil & Gas and more...

Umuthi Healthcare Solutions Plc, the technology led healthcare business focused on the distribution of pharmaceuticals and the provision of medical facilities in remote areas, seeking admission to the Standard Listing segment of the Official List  The Hut Group.  Expected intention to float on the Main Market.

ImmuPharma PLC - Small Cap Wrap - Strix Group, ProPhotonix, Nostra Terra Oil & Gas and more...

2 Sep 2020


*A corporate client of Hybridan LLP


Dish of the day

Kooth (AIM:COO)  is the UK's largest digital mental health provider to the NHS for children and young people (CYP) aged 10-25 years old by providing a broad range of therapeutic tools and interventions.   £16m raise. Mkt cap expected £66m.


Off the menu

BeHeard has left AIM following an acquisition by MSQ Partners.


What’s cooking in the IPO kitchen?

Umuthi Healthcare Solutions Plc, the technology led healthcare business focused on the distribution of pharmaceuticals and the provision of medical facilities in remote areas, seeking admission to the Standard Listing segment of the Official List 

The Hut Group.  Expected intention to float on the Main Market. THG is a vertically integrated digital-first consumer brands group, retailing its own brands in beauty and nutrition plus third party brands, via its proprietary technology platform to an online and global customer base. For the year ended 31 December 2019, THG's revenue was £1.1 billion, up 24.5 per cent. year-on-year, and its Adjusted EBITDA was £111.3 million, representing an Adjusted EBITDA margin of 9.8 per cent . The Company has experienced an acceleration in growth during 2020, with revenue of £676 million, up 35.8 per cent. on the equivalent prior year period , achieved in the 6 months to 30 June 2020, which the Directors believe evidenced the non-discretionary nature of the nutrition and beauty categories .

Kibo Energy PLC, the multi-asset Africa focused energy company, is seeking admission for its 100% owned UK subsidiary Sloane Developments Ltd , which will be renamed Mast Energy Developments PLC (MED), to the Standard List of the London Stock Exchange plc . Targeted for Q4 2020. The MED business strategy is to acquire and develop a portfolio of flexible small-scale power generation assets, exploiting a growth niche market in the UK for Reserve Power generation to balance out the national grid at critical times. 


Banquet Buffet

European Lithium 0.0575p  £38.5m (AQSE:EUR)

As part of the Company's strategic engagement with Talaxis, a global leader in EV technology metals project development, EUR has appointed Mr Kimon Gkomozias as Executive Director 

· Kimon will drive the Company's financing efforts and identification of strategic development partners for the Company's Wolfsberg Lithium Project in Austria 

· As part of the appointment, Company intends to complete a placement of AUD$2m at $0.045 with a 1 for 4 Option ($0.05, 31 July 2022)

Sunrise Resources 0.29p  £10.5m (LON:SRES)

CS Project Mine Permit Appeal Period Closed. No Appeals Submitted 

Further to the Company's announcement of 29 July 2020, the Company has been advised that that no appeals have been lodged against the decision of the Bureau of Land Management (BLM) to authorise mining operations at the Company's CS Pozzolan-Perlite Project in Nevada, USA and that the appeal period is now closed. Commenting today Sunrise Executive Chairman Patrick Cheetham said : "We are pleased to see that the various appeal periods are passing without any objections or appeals and that we now have a clear green light for the mine development from both the BLM and BMRR. I think this reflects the thorough work that went into the Environmental Assessment and the positive green credentials of the CS Project."


Live Company 10p  £8.8m (LON:LVCG)

A new contract with Hadran in Israel for Brickosaurs has been signed. The new tour will run from October 2020 until May 2021.   

Chairman David Ciclitira said:

 "Our strategy of maximising year-round asset utilisation by continuing to build on our relationships in the Southern Hemisphere has started to come into fruition. This means that BRICKOSAURS is now sold out until November 2021 with ongoing discussions for it to tour in Asia throughout 2022. We also have signed contracts in South Africa with BRICKLIVE OCEAN for December 2020 and are in advanced conversations with clients in Australia for a potential Touring Show at the end of 2021."

The Group is a network of partner-driven fan-based shows using BRICKLIVE created content worldwide. The Company owns the rights to BRICKLIVE - an interactive experience built around the creative ethos of the world's most popular construction toy bricks. 


Strix Group 238.75p  £475m (LON:KETL)

The specialist in the design, manufacture and supply of kettle safety controls and other complementary water temperature management components, is pleased to announce the launch of its HaloPure technology water purification and disinfection solution within the livestock farming industry in the People's Republic of China ("PRC"). 

The HaloPure technology, acquired from HaloSource in March 2019, has a unique ability to not only treat raw incoming water, but also maintain an ongoing sanitised environment throughout the water line, which is a perfect application for industries reliant on long distance water lines with significant bacteria contamination such as livestock farming.  In the PRC alone, over 15 billion poultry and pigs are farmed annually. The total addressable market is estimated at RMB 5 billion, with Strix focusing on the higher end, automated farms worth approximately RMB500 million which have been growing rapidly.


ProPhotonix 1.4p  £1.3m (LON:PPIX)

The designer and manufacturer of LED illumination systems and laser diode modules with operations in Ireland and the United Kingdom, is pleased to announce the extension of its range of PROdigii digital laser modules with five new wavelengths: 375nm, 405nm, 450nm, 905nm and 940nm. 

With these additional wavelengths in the UV, blue and IR range at output powers up to 500mW, ProPhotonix can now offer digital laser solutions for many additional applications. The 375nm PROdigii digital laser provides an ideal solution for UV curing and fluorescing applications. Two wavelengths have been added in the blue range, a 405nm digital laser ideal for 3D printing and particle measurement and a 450nm laser module ideal for spectroscopy. The new 905nm and 940nm infrared digital lasers are well suited to robotics and gesture recognition as well as LiDAR applications.


Nostra Terra Oil & Gas 0.325p  £1.16m (LON:NTOG)

Acquisition of a 100% Working Interest in the Caballos Creek Oil Field, a producing oil field with additional development opportunity in Atascosa County Texas.

 Highlights. · Independently assessed PV10 US$1,052,300 for proved reserves

o Proved reserves as at 30 June 2020 of 92,100 boe (gross) o Remaining economic life of 16 - 32 years per well

· Shallow, conventional, oil producing assets · 745 acres, all held-by-production ("HBP")

· 100% working interest ("WI"), with NTOG assuming operatorship · 30 bopd current production (gross), which increases Company-wide production by circa 25% · Financed entirely without dilution · Estimated payback less than 2 years


Immupharma 13.725p  £25.1m (LON:IMM)

£6.5m placing at 11p. . The Placing Price represents a 27.6% discount to the 7 day volume weighted average price of the Company's shares on AIM on 1 September 2020. The proceeds from the Placing, net of fees and expenses, are expected to be approximately £5.9 million and  will be used to progress the Company's therapeutic pipeline including one of its new developments, BioAMP-B, a novel peptide-based drug that offers a potential treatment for many serious and life threatening fungal infections such as aspergillosis (lung infection). Funds will also provide the Company with additional working capital.


Oncimmune Holdings 153.4p  £97.5m (LON:ONC)

The global immunodiagnostics group, today announces it has signed an autoantibody profiling collaboration with a leading global biopharmaceutical company with extensive experience in developing novel immune checkpoint inhibitors ("CPIs") . The programme, which is scheduled to complete in Q2 2021, will evaluate the autoantibody profiles from patient samples collected in a clinical trial of a CPI. Such profiling is expected to enable the biopharmaceutical partner to identify better the groups of patients likely to both tolerate a particular CPI treatment and also those whose disease is likely to respond positively to that treatment.


BlueRock Diamonds 49p  £4.4m (LON:BRD)

The diamond producer, which owns and operates the Kareevlei Diamond Mine in the Kimberley region of South Africa,  announced the sale of 3,805 carats at an average price of USD330 per carat for an aggregate consideration of USD1,255,000.


BlueRock Executive Chairman, Mike Houston, said,  "Our diamonds remain attractive to buyers even in what continues to be an uncertain market.  Similar to the sale announced in June 2020, this was a private sale conducted through a sales agent in South Africa.  We are pleased with the price achieved which is above our internal budget and a 14% increase over the price achieved in June 2020.


Thor Mining 0.77p  £9.8m (LON:THR)

Assays from the latest stream sediment sampling program substantially exceeded management expectations at the 100% owned Pilbara Goldfield tenements, to be called Ragged Range (E46/1262 and E46/1190), in Western Australia. The stream sediment Bulk Leach Extractable Gold (BLEG) samples were part of the second phase geochemistry program, now complete, following up on results from October 2019.

Sampling results have now defined an overall broader target zone of 13 x 1 km of highly anomalous gold, demonstrating the potential to host a significant gold bearing system. · Samples defining the 13km gold target zone are from separate drainage catchments supporting the potential of gold mineralisation along the entire strike length. · Next steps to commence immediately include; further mapping, stream sediment  and soil sampling, and a detailed aeromagnetic survey.


If you would like to unsubscribe, please email [email protected] with “unsubscribe me”.


Head Chef

Derren Nathan

0203 764 2344

[email protected]

Status of this Note and Disclaimer

This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document is sent to you as market commentary only. As market commentary this document does not constitute any of (i) investment research and financial analysis or other forms of general recommendation relating to transactions in financial instruments for the purposes of section B of annex I to Directive 2014/65/EU ("MIFID II Directive"); or (ii) investment research as defined in article 36(1) of Commission Delegated Regulation 2017/565/EU made pursuant to the MIFID II              Directive; or (iii) non-independent research (as such term is defined in the Financial Conduct Authority's Conduct of Business Sourcebook).

This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii)  persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Scotgold 'expected to command a significant premium in the market' says...

Mining capital's Alastair Ford explains the significance of Scotgold Resources' (LON:SGZ) first gold pour at its Cononish mine, marking a milestone to becoming Scotland’s first commercial gold and silver operation. The company is now focused on completing an accelerated expansion plan to...

24 minutes ago

13 min read